The Latest Breaking News from FDA

Litigation over abortion drugs turns disagreements about individual rights into a bureaucratic tussle.

The Food and Drug Administration (FDA) has warned people not to consume a certain lot of roasted nori seaweed products due to potential contamination of cadmium.

The drug had been fast-tracked for approval under the agency's accelerated approval program, and has been available for more than a decade, despite the drugmaker's failure to prove that it works.

The candy manufacturer defended using the food dye on the basis that it is ‘currently an approved colourant for use in candy by the FDA’

Recent banking turmoil and rising interest rates have weighed heavily on investors’ sentiment lately. However, weak economic data signaling slowing growth could result in relatively easy monetary policies in the second half of 2023. Given the macroeconomic backdrop, investors could consider adding fundamentally sound low P/E stocks Pfizer (PFE), Chevron…

The Food and Drug Administration is ordering an unproven drug intended to prevent premature births off the market

Cutting-edge new tech could halt animal testing in drug development — but some old-fashioned methods may stick around.

WASHINGTON — At the tender age of 75, Peter Welch is starting from scratch, in a way. Welch became one of the oldest freshmen to ever roam the Senate’s hallways after winning the seat vacated by one of the longest-serving senators ever, Patrick Leahy.

WASHINGTON — The broad outlines of an upcoming debate over a pandemic preparedness reauthorization bill are beginning to emerge as regulators, policymakers and industry groups take stock of lessons learned from COVID-19.

Millions of people are scrambling to navigate the Adderall shortage in a saga closely watched by investors in Teva and other drug stocks. Here's what you should know.

A reauthorization of the pandemic preparedness law will give Congress a chance to revisit its handling of COVID-19.